1,111 reports of this reaction
3.8% of all ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, manufactured by Haleon US Holdings LLC. There are 1,111 FDA adverse event reports linking ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE to HEADACHE. This represents approximately 3.8% of all 29,082 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 1,111 FDA reports for ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.8% of all adverse event reports for ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, making it a notable side effect.
If you experience headache while taking ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.